BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18615108)

  • 1. Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids.
    Lönnerholm G; Nordgren A; Frost BM; Jonsson OG; Kanerva J; Nygaard R; Schmiegelow K; Larsson R; Forestier E
    Leukemia; 2009 Jan; 23(1):209-12. PubMed ID: 18615108
    [No Abstract]   [Full Text] [Related]  

  • 2. The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial.
    Zachariadis V; Gauffin F; Kuchinskaya E; Heyman M; Schoumans J; Blennow E; Gustafsson B; Barbany G; Golovleva I; Ehrencrona H; Cavelier L; Palmqvist L; Lönnerholm G; Nordenskjöld M; Johansson B; Forestier E; Nordgren A; ;
    Leukemia; 2011 Apr; 25(4):622-8. PubMed ID: 21242996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation t(1;19) is related to low cellular drug resistance in childhood acute lymphoblastic leukaemia.
    Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonmundsson G; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
    Leukemia; 2005 Jan; 19(1):165-9. PubMed ID: 15526029
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.
    Pichler H; Möricke A; Mann G; Teigler-Schlegel A; Niggli F; Nebral K; König M; Inthal A; Krehan D; Dworzak MN; Janousek D; Harbott J; Schrappe M; Gadner H; Strehl S; Haas OA; Panzer-Grümayer R; Attarbaschi A;
    Br J Haematol; 2010 Apr; 149(1):93-100. PubMed ID: 20067563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-random chromosome abnormality found in precursor-B lineage acute lymphoblastic leukaemia: dic(9;20)(p1?3;q11).
    Slater R; Smit E; Kroes W; Bellomo MJ; Mühlematter D; Harbott J; Behrendt H; Hählen K; Veerman AJ; Hagemeijer A
    Leukemia; 1995 Oct; 9(10):1613-9. PubMed ID: 7564498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2.
    Schoumans J; Johansson B; Corcoran M; Kuchinskaya E; Golovleva I; Grandér D; Forestier E; Staaf J; Borg A; Gustafsson B; Blennow E; Nordgren A
    Br J Haematol; 2006 Nov; 135(4):492-9. PubMed ID: 16999846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and cytogenetic features of pediatric dic(9;20)(p13.2;q11.2)-positive B-cell precursor acute lymphoblastic leukemias: a Nordic series of 24 cases and review of the literature.
    Forestier E; Gauffin F; Andersen MK; Autio K; Borgström G; Golovleva I; Gustafsson B; Heim S; Heinonen K; Heyman M; Hovland R; Johannsson JH; Kerndrup G; Rosenquist R; Schoumans J; Swolin B; Johansson B; Nordgren A; ; ;
    Genes Chromosomes Cancer; 2008 Feb; 47(2):149-58. PubMed ID: 17990329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homozygous deletions of CDKN2A are present in all dic(9;20)(p13·2;q11·2)-positive B-cell precursor acute lymphoblastic leukaemias and may be important for leukaemic transformation.
    Zachariadis V; Schoumans J; Barbany G; Heyman M; Forestier E; Johansson B; Nordenskjöld M; Nordgren A
    Br J Haematol; 2012 Nov; 159(4):488-91. PubMed ID: 22994152
    [No Abstract]   [Full Text] [Related]  

  • 9. L-asparaginase induced severe hypertriglyceridemia in acute lymphoblastic leukemia with 11q23 abnormality.
    Jain S; Naithani R; Kapoor G; Nath T
    Leuk Res; 2009 Nov; 33(11):e194. PubMed ID: 19487026
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of E coli or Erwinia asparaginase and corticotherapy on fibrinogen concentration in induction of acute lymphoblastic leukemia in children].
    Astruc D; Nowak V; Grunebaum L; Wiesel ML; Cazenave JP; Babin-Boilletot A; Lutz P
    Arch Pediatr; 1994 Jun; 1(6):617-8. PubMed ID: 7994359
    [No Abstract]   [Full Text] [Related]  

  • 11. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and molecular cytogenetic characteristics of dic(9;20) in adult acute lymphoblastic leukemia: a case report of three patients.
    Song X; Gong S; Yang J; Wang J
    Ann Hematol; 2007 May; 86(5):347-51. PubMed ID: 17245591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Building better therapy for children with acute lymphoblastic leukemia.
    Carroll WL; Raetz EA
    Cancer Cell; 2005 Apr; 7(4):289-91. PubMed ID: 15837616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia.
    Hongo T; Yamada S; Yajima S; Watanabe C; Fujii Y; Kawasaki H; Yazaki M; Hanada R; Horikoshi Y
    Int J Hematol; 1999 Dec; 70(4):268-77. PubMed ID: 10643153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two additional cases of t dic(9:12) in acute lymphocytic leukemia (ALL): prognosis in ALL with dic(9:12).
    Huret JL; Heerema NA; Brizard A; Provisor AJ; Benz-Lemoine E; Guilhot F; Savage JR; Tanzer J
    Leukemia; 1990 Jun; 4(6):423-5. PubMed ID: 2193203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission induction therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of vincristine, corticosteroids, L-asparaginase and anthracyclines.
    Ronghe M; Burke GA; Lowis SP; Estlin EJ
    Cancer Treat Rev; 2001 Dec; 27(6):327-37. PubMed ID: 11908926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protocol.
    Kuchinskaya E; Heyman M; Nordgren A; Söderhäll S; Forestier E; Wehner P; Vettenranta K; Jonsson O; Wesenberg F; Sahlén S; Nordenskjöld M; Blennow E
    Br J Haematol; 2011 Mar; 152(5):615-22. PubMed ID: 21241277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.
    Lauten M; Cario G; Asgedom G; Welte K; Schrappe M
    Haematologica; 2003 Nov; 88(11):1253-8. PubMed ID: 14607754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detecting dic(9;20)(p13.2;p11.2)-positive B-cell precursor acute lymphoblastic leukemia in a clinical setting using fluorescence in situ hybridization.
    Zachariadis V; Schoumans J; Ofverholm I; Barbany G; Halvardsson E; Forestier E; Johansson B; Nordenskjöld M; Nordgren A
    Leukemia; 2014 Jan; 28(1):196-8. PubMed ID: 23787394
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.